[go: up one dir, main page]

SI1105391T1 - Imidazo(1,2-a)pyridine compounds that inhibit gastric acid secretion, pharmaceutical compositions thereof, and processes for thier preparation - Google Patents

Imidazo(1,2-a)pyridine compounds that inhibit gastric acid secretion, pharmaceutical compositions thereof, and processes for thier preparation

Info

Publication number
SI1105391T1
SI1105391T1 SI9930698T SI9930698T SI1105391T1 SI 1105391 T1 SI1105391 T1 SI 1105391T1 SI 9930698 T SI9930698 T SI 9930698T SI 9930698 T SI9930698 T SI 9930698T SI 1105391 T1 SI1105391 T1 SI 1105391T1
Authority
SI
Slovenia
Prior art keywords
imidazo
processes
pharmaceutical compositions
gastric acid
acid secretion
Prior art date
Application number
SI9930698T
Other languages
English (en)
Slovenian (sl)
Inventor
Kosrat Amin
Mikael Dahlstrm
Peter Nordberg
Ingemar Starke
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of SI1105391T1 publication Critical patent/SI1105391T1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
SI9930698T 1998-08-21 1999-08-18 Imidazo(1,2-a)pyridine compounds that inhibit gastric acid secretion, pharmaceutical compositions thereof, and processes for thier preparation SI1105391T1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9802794A SE9802794D0 (sv) 1998-08-21 1998-08-21 New compounds
PCT/SE1999/001402 WO2000011000A2 (fr) 1998-08-21 1999-08-18 Nouveaux composes

Publications (1)

Publication Number Publication Date
SI1105391T1 true SI1105391T1 (en) 2005-02-28

Family

ID=20412307

Family Applications (1)

Application Number Title Priority Date Filing Date
SI9930698T SI1105391T1 (en) 1998-08-21 1999-08-18 Imidazo(1,2-a)pyridine compounds that inhibit gastric acid secretion, pharmaceutical compositions thereof, and processes for thier preparation

Country Status (20)

Country Link
US (3) US6579884B1 (fr)
EP (2) EP1411056A3 (fr)
JP (1) JP2002523415A (fr)
KR (1) KR20010072798A (fr)
CN (1) CN1329613A (fr)
AR (1) AR020226A1 (fr)
AT (1) ATE280768T1 (fr)
AU (1) AU5767999A (fr)
BR (1) BR9913103A (fr)
CA (1) CA2339286A1 (fr)
DE (1) DE69921483T2 (fr)
DK (1) DK1105391T3 (fr)
ES (1) ES2229763T3 (fr)
IL (1) IL141166A0 (fr)
NO (1) NO20010860L (fr)
PT (1) PT1105391E (fr)
SE (1) SE9802794D0 (fr)
SI (1) SI1105391T1 (fr)
WO (1) WO2000011000A2 (fr)
ZA (1) ZA200100913B (fr)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9802794D0 (sv) * 1998-08-21 1998-08-21 Astra Ab New compounds
SE0003186D0 (sv) * 2000-09-07 2000-09-07 Astrazeneca Ab New process
UA80393C2 (uk) 2000-12-07 2007-09-25 Алтана Фарма Аг Фармацевтична композиція, яка містить інгібітор фде 4, диспергований в матриці
SE0102808D0 (sv) * 2001-08-22 2001-08-22 Astrazeneca Ab New compounds
MY140561A (en) 2002-02-20 2009-12-31 Nycomed Gmbh Dosage form containing pde 4 inhibitor as active ingredient
CA2499593C (fr) * 2002-09-19 2011-08-16 Michael P. Dwyer Pyrazolopyridines utilisees comme inhibiteurs de la kinase dependante des cyclines
CA2499639C (fr) * 2002-09-19 2011-11-08 Schering Corporation Nouvelles imidazopyridines utilisees comme inhibiteurs des kinases dependantes des cyclines
ES2335498T3 (es) 2003-03-10 2010-03-29 Nycomed Gmbh Nuevo proceso para la preparacion de reflumilast.
SE0301904D0 (sv) 2003-06-26 2003-06-26 Astrazeneca Ab Novel imidazopyridine compound II with therapeutic effect
US8536492B2 (en) * 2003-10-27 2013-09-17 Applied Materials, Inc. Processing multilayer semiconductors with multiple heat sources
CA2544325A1 (fr) 2003-11-03 2005-05-12 Astrazeneca Ab Procede d'utilisation
EP1711498A2 (fr) * 2004-01-26 2006-10-18 Altana Pharma AG 1,2,4-triazolo¬1,5-a|pyridines inhibant la secretion d'acide gastrique
ATE527258T1 (de) * 2004-07-28 2011-10-15 Takeda Pharmaceutical Pyrroloä2,3-cüpyridinverbindung, verfahren zu deren herstellung und anwendung
EP2258350B1 (fr) * 2005-03-16 2014-12-24 Takeda GmbH Forme de dosage cachant le goût comprenant du roflumilast
EP2099798A1 (fr) * 2006-12-01 2009-09-16 Galapagos N.V. Composés d'imidazolopyridine pour le traitement des maladies dégénératives et inflammatoires
CA2700841A1 (fr) * 2007-09-27 2009-04-02 The United States Of America, As Represented By The Secretary, Departmen T Of Health And Human Services Composes d'isoindoline pour le traitement d'une amyotrophie spinale et autres utilisations
MX2012000275A (es) 2009-07-09 2012-02-08 Raqualia Pharma Inc Antagonista de bomba de acido para el tratamiento de enfermedades involucradas en la motilidad gastrointestinal anormal.
CN111606846A (zh) * 2020-05-12 2020-09-01 广州理文科技有限公司 一种n`-三氟甲磺酰基n杂芳香胺类化合物及其制备方法
WO2025058459A1 (fr) * 2023-09-15 2025-03-20 (주)휴온스 Nouveau composé à base d'imidazopyridine et composition le comprenant en tant que principe actif pour prévenir, soulager ou traiter des maladies inflammatoires gastro-intestinales ou des maladies associées à l'acide gastrique

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA81219B (en) * 1980-01-23 1982-01-27 Schering Corp Imidazo (1,2-a) pyridines ,process for their preparation and pharmaceutical compositions containing them
DE3269604D1 (en) * 1981-06-26 1986-04-10 Schering Corp Novel imidazo(1,2-a)pyridines and pyrazines, processes for their preparation and pharmaceutical compositions containing them
US4725601A (en) * 1985-06-04 1988-02-16 Fujisawa Pharmaceutical Co., Ltd. Certain imidazo[1,2-a]pyridines useful in the treatment of ulcers
US5574042A (en) * 1992-11-02 1996-11-12 Fujisawa Pharmaceutical Co., Ltd Imidazo [1,2-a] pyridines and their pharmaceutical use
IL108520A (en) * 1993-02-15 1997-09-30 Byk Gulden Lomberg Chem Fab 2, 3, 8-TRISUBSTITUTED IMIDAZO £1, 2-a| PYRIDINE DERIVATIVES, PROCESSES FOR THE PREPARATION THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
WO1994024130A1 (fr) * 1993-04-22 1994-10-27 Byk Gulden Lomberg Chemische Fabrik Gmbh Nouveaux sels de pyridinium et leur utilisation pour combattre des bacteries helicobacter
UA48122C2 (uk) * 1993-10-11 2002-08-15 Бік Гульден Ломберг Хеміше Фабрік Гмбх АЛКОКСІАЛКІЛКАРБАМАТИ ІМІДАЗО[1,2-а]ПІРИДИНІВ, СПОСІБ ЇХ ОДЕРЖАННЯ ТА ЛІКАРСЬКИЙ ЗАСІБ НА ЇХ ОСНОВІ
NZ290818A (en) 1994-07-28 1998-10-28 Byk Gulden Lomberg Chem Fab Benzyl-imidazopyridines
CA2196076A1 (fr) 1994-07-28 1996-02-08 Gerhard Grundler Acylimidazopyridines
SK197A3 (en) * 1994-07-28 1997-06-04 Byk Gulden Lomberg Chem Fab Imidazopyridine-azolidinones, preparation method thereof, pharmaceutical composition containing same and their use
AU3221795A (en) 1994-07-28 1996-02-22 Byk Gulden Lomberg Chemische Fabrik Gmbh Halogenated imidazopyridines
DE19602853A1 (de) * 1996-01-26 1997-07-31 Byk Gulden Lomberg Chem Fab Neue Halogenimidazopyridine
US6096758A (en) 1996-01-26 2000-08-01 Byk Gulden Lomberg Chemische Fabrik Gmbh 3-methylimidazopyridines
SE9700661D0 (sv) * 1997-02-25 1997-02-25 Astra Ab New compounds
SE9801526D0 (sv) * 1998-04-29 1998-04-29 Astra Ab New compounds
SE9802793D0 (sv) * 1998-08-21 1998-08-21 Astra Ab New compounds
SE9802794D0 (sv) * 1998-08-21 1998-08-21 Astra Ab New compounds

Also Published As

Publication number Publication date
US6790960B2 (en) 2004-09-14
DK1105391T3 (da) 2005-01-24
US6579884B1 (en) 2003-06-17
NO20010860D0 (no) 2001-02-20
DE69921483T2 (de) 2006-02-02
ZA200100913B (en) 2002-05-02
ES2229763T3 (es) 2005-04-16
EP1411056A3 (fr) 2004-04-28
IL141166A0 (en) 2002-02-10
WO2000011000A3 (fr) 2000-06-15
EP1411056A2 (fr) 2004-04-21
SE9802794D0 (sv) 1998-08-21
US20030220364A1 (en) 2003-11-27
DE69921483D1 (de) 2004-12-02
AU5767999A (en) 2000-03-14
PT1105391E (pt) 2005-01-31
EP1105391B1 (fr) 2004-10-27
BR9913103A (pt) 2001-05-08
ATE280768T1 (de) 2004-11-15
US20050154007A1 (en) 2005-07-14
WO2000011000A2 (fr) 2000-03-02
KR20010072798A (ko) 2001-07-31
CN1329613A (zh) 2002-01-02
CA2339286A1 (fr) 2000-03-02
AR020226A1 (es) 2002-05-02
NO20010860L (no) 2001-04-23
JP2002523415A (ja) 2002-07-30
EP1105391A2 (fr) 2001-06-13

Similar Documents

Publication Publication Date Title
SI1105391T1 (en) Imidazo(1,2-a)pyridine compounds that inhibit gastric acid secretion, pharmaceutical compositions thereof, and processes for thier preparation
HUP0102425A3 (en) Imidazo pyridine derivatives which inhibit gastric acid secretion, process for producing them and pharmaceutical compositions containing them
HUP0200450A3 (en) Cephen derivatives containing an imidazo[4,5-b]pyridiniummethyl moiety, process for their preparation and pharmaceutical compositions of the same
AU7922900A (en) Thiazole and imidazo (4,5-b) pyridine compounds and their pharmaceutical use
HUT72448A (en) O-, n- ors-containing heterobicyclic compounds, pharmaceutical compositions comprising them and process for their preparation
HUP0303148A3 (en) 4,5-dihydro-1h-pyrazole derivatives having cb1-antagonistic activity, pharmaceutical compositions containing the compounds and processes for their preparation
IL131415A (en) Anti-inflammatory compounds, processes for their preparation and pharmaceutical compositions comprising them
IL100899A0 (en) Beta-amino-alpha-hydroxycarboxylic acid derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
EE04060B1 (et) Heterotsüklilised ühendid maohappesekretsiooni inhibeerimiseks, protsess nende valmistamiseks ja ravimkoostised
IL110286A0 (en) Pyrido(2,3-d) pyridazin-5-one and pyrido(2,3-d)pyridazin-5-thione derivatives, processes for their preparation and herbicidal compositions containing them
HUP0203542A3 (en) 3(5)-amino-pyrazole derivatives, process for their preparation, their use and pharmaceutical compositions containing the same
IL138969A0 (en) Anthranilic acid derivatives, processes for the preparation thereof and pharmaceutical compositions containing the same
HUP0105054A3 (en) Imidazo[4,5-c]-pyridine-4-on-derivatives, pharmaceutical compositions containing them and process for their preparation
IL113263A0 (en) Imidazo pyridine compounds and pharmaceutical compositions for the treatment of gastrointestinal diseases
HU9302741D0 (en) Gastric acid secretion inhibiting new pyrrolo[2,3-b]pyridine derivatives
EP0499416A3 (en) Pyridine compounds as angiotensin ii antagonists, processes for their preparation and pharmaceutical compositions containing them
IL141165A0 (en) New imidazopyridine compounds for the inhibition of acid secretion, pharmaceutical compositions thereof and process for preparing the same
IL190120A0 (en) PREPARATION OF 9-AMINO OCTAHYDRO-6,10-DIOXO-6H-PYRIDAZINO/1,2-a//1,2/DIAZEPIN-1-CARBOXYLIC ACID DERIVATIVES
IL140414A0 (en) Beta lactam compounds, processes for the preparation thereof and pharmaceutical compositions containing the same
HUP0103788A3 (en) Processes for the preparation of 5-hydroxy-3-oxopentanoic acid derivatives
NZ224032A (en) Imidazo(1,2-a)pyridine derivatives and pharmaceutical compositions
SI1275647T1 (en) Octahydro-2H-pyrido(1,2-a)pyrazine derivatives, process for their preparation and pharmaceutical compositions containing them
HUP0300569A3 (en) Pyrano[2,3-c]imidazo[-1,2-a]pyridine derivatives for the treatment of gastrointestinal disorders and pharmaceutical compositions containing the compounds
IL157461A0 (en) Use of carboxamido imidazo [1,2] pyridine deivatives in the preparation of medicaments for treating or preventing gastric ulcer
IL82532A0 (en) Pyrazolo(3,4-b)pyridine derivatives,processes for the preparation thereof and herbicidal compositions containing the same